Use of compatible solutes as substances having free radical scavenging properties
OwnerThomas Schwarzinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of compatible solutes selected from the group comprised of di-myo-inositol phosphate (DIP), cyclic 2,3 diphosphoglycerate (cDPG), 1,1-di-glyccrol phosphate (DGP), β-mannosylglycerate (firoin) β-mannosylglyceramide (firoin-A) and/or di-mannosyl-di-inositol phosphate (DMIP) and/or of derivatives of these compounds or combinations thereof for protecting organisms, organs, tissues, cells or the organic building blocks thereof from chemical radicals and oxidatively active compounds.
Claims11
Use of compatible solutes selected from the group comprised of myo-inositol phosphate (DIP), cyclic 2,3 diphosphoglycerate (cDPG), 1,1-di-glycerol phosphate (DGP), β-mannosylglycerate (firoin), β-mannosylglyceramide (firoin-A) or/and di-mannosyl-di-inositol phosphate (DMIP) and/or derivates of these compounds or combinations thereof for protecting organisms, organs, tissues, cells or the organic buildings blocks thereof from chemical radicals and oxidatively active compounds.
Method for the protection of organisms, organs, tissues, cells or the organic building blocks thereof from free radicals and oxidatively active compounds, wherein compatible solutes are added to a sample containing the organisms, organs, tissues, cells or the organic building blocks thereof.
Use of compatible solutes for the production of a medicine for the treatment of diseases that are caused by free radical and oxidant activity.
Use of compatible solutes for the production of a cosmetic and/or dermatological preparation for the prevention and treatment of skin damage or skin disorders caused by free radical and oxidant activity.
Use of compatible solutes for the production of a food product for the prevention and treatment of damage or alteration to organisms caused by free radical and oxidant activity.
Dependencies are inferred from the claim text.